{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:16:28Z","timestamp":1792880188913,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"UAM-Banco Santander","award":["SN\/2013"],"award-info":[{"award-number":["SN\/2013"]}],"id":[{"id":"https:\/\/ror.org\/017d1hs72","id-type":"ROR","asserted-by":"crossref"}]},{"name":"CEAL","award":["CEAL-AL\/2015-11"],"award-info":[{"award-number":["CEAL-AL\/2015-11"]}]},{"name":"Fondo de Investigaciones Sanitarias","award":["PS09\/00538"],"award-info":[{"award-number":["PS09\/00538"]}]},{"DOI":"10.13039\/501100006541","name":"Consejer\u00eda de Sanidad, Comunidad de Madrid","doi-asserted-by":"publisher","award":["CC08-UAM\/SAL-4440\/08"],"award-info":[{"award-number":["CC08-UAM\/SAL-4440\/08"]}],"id":[{"id":"10.13039\/501100006541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007748","name":"IVIC","doi-asserted-by":"crossref","award":["IVIC-1365"],"award-info":[{"award-number":["IVIC-1365"]}],"id":[{"id":"10.13039\/501100007748","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2324-x","type":"journal-article","created":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T11:48:59Z","timestamp":1490096939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Differential cytokine profiling in Chagasic patients according to their arrhythmogenic-status"],"prefix":"10.1186","volume":"17","author":[{"given":"H\u00e9ctor","family":"Rodr\u00edguez-Angulo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Villegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Mijares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Giron\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Fresno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,21]]},"reference":[{"issue":"10","key":"2324_CR1","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2471\/BLT.13.134072","volume":"92","author":"Y Jackson","year":"2014","unstructured":"Jackson Y, Varcher Herrera M, Gascon J. Economic crisis and increased immigrant mobility: new challenges in managing Chagas disease in Europe. Bull World Health Organ. 2014;92(10):771\u20132.","journal-title":"Bull World Health Organ"},{"issue":"2","key":"2324_CR2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4269\/ajtmh.14-0483","volume":"92","author":"R Salazar","year":"2014","unstructured":"Salazar R, Castillo-Neyra R, Tustin AW, Borrini-Mayori K, Naquira C, Levy MZ. Bed Bugs (Cimex lectularius) as Vectors of Trypanosoma cruzi. AmJTrop Med Hyg. 2014;92(2):331\u20135.","journal-title":"AmJTrop Med Hyg."},{"key":"2324_CR3","first-page":"247","volume":"29","author":"IMF Mendoza","year":"1999","unstructured":"Mendoza IMF, Marques J, Misticchio F, Matheus A. Rodriguez, A. Ventricular tachycardia in Chagas heart disease. Ital Card. 1999;29:247\u201350.","journal-title":"Ital Card"},{"issue":"Suppl 1","key":"2324_CR4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1590\/S0074-02762009000900021","volume":"104","author":"A Rassi Jr","year":"2009","unstructured":"Rassi Jr A, Rassi A, Marin-Neto JA. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Memorias do Instituto Oswaldo Cruz. 2009;104(Suppl 1):152\u20138.","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"key":"2324_CR5","doi-asserted-by":"crossref","unstructured":"Ribeiro AL, Cavalvanti PS, Lombardi F, Nunes Mdo C, Barros MV, Rocha MO;Prognostic value of signal-averaged electrocardiogram in Chagas disease. J Cardiovasc Electrophysiol 2008;19(5):502-509.","DOI":"10.1111\/j.1540-8167.2007.01088.x"},{"issue":"3","key":"2324_CR6","volume":"9","author":"GR Sousa","year":"2014","unstructured":"Sousa GR, Gomes JA, Fares RC, Damasio MP, Chaves AT, Ferreira KS, Nunes MC, Medeiros NI, Valente VA, Correa-Oliveira R, et al. Plasma cytokine expression is associated with cardiac morbidity in chagas disease. PLoS One. 2014;9(3):e87082.","journal-title":"PLoS One"},{"issue":"4","key":"2324_CR7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001630","volume":"6","author":"PM Guedes","year":"2012","unstructured":"Guedes PM, Gutierrez FR, Silva GK, Dellalibera-Joviliano R, Rodrigues GJ, Bendhack LM, Rassi Jr A, Rassi A, Schmidt A, Maciel BC, et al. Deficient regulatory T cell activity and low frequency of IL-17-producing T cells correlate with the extent of cardiomyopathy in human Chagas' disease. PLoS Negl Trop Dis. 2012;6(4):e1630.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"2324_CR8","volume":"4","author":"PM Matta Guedes da","year":"2010","unstructured":"da Matta Guedes PM, Gutierrez FR, Maia FL, Milanezi CM, Silva GK, Pavanelli WR, Silva JS. IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis. PLoS Negl Trop Dis. 2010;4(2):e604.","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"2324_CR9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065820","volume":"8","author":"C Sanoja","year":"2013","unstructured":"Sanoja C, Carbajosa S, Fresno M, Girones N. Analysis of the dynamics of infiltrating CD4(+) T cell subsets in the heart during experimental Trypanosoma cruzi infection. PLoS One. 2013;8(6):e65820.","journal-title":"PLoS One"},{"issue":"8","key":"2324_CR10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/pim.12107","volume":"36","author":"WO Dutra","year":"2014","unstructured":"Dutra WO, Menezes CA, Magalhaes LM, Gollob KJ. Immunoregulatory networks in human Chagas disease. Parasite Immunol. 2014;36(8):377\u201387.","journal-title":"Parasite Immunol"},{"issue":"17","key":"2324_CR11","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1161\/01.CIR.0000062690.79456.D0","volume":"107","author":"JS Leon","year":"2003","unstructured":"Leon JS, Wang K, Engman DM. Captopril ameliorates myocarditis in acute experimental Chagas disease. Circulation. 2003;107(17):2264\u20139.","journal-title":"Circulation"},{"issue":"3","key":"2324_CR12","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2249.2010.04270.x","volume":"162","author":"JS Coelho dos Santos","year":"2010","unstructured":"Coelho dos Santos JS, Menezes CA, Villani FN, Magalhaes LM, Scharfstein J, Gollob KJ, Dutra WO. Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells. Clin Exp Immunol. 2010;162(3):528\u201336.","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"2324_CR13","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1128\/AAC.00207-12","volume":"56","author":"G Benaim","year":"2012","unstructured":"Benaim G, Hernandez-Rodriguez V, Mujica-Gonzalez S, Plaza-Rojas L, Silva ML, Parra-Gimenez N, Garcia-Marchan Y, Paniz-Mondolfi A, Uzcanga G. In vitro anti-Trypanosoma cruzi activity of dronedarone, a novel amiodarone derivative with an improved safety profile. Antimicrob Agents Chemother. 2012;56(7):3720\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2324_CR14","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/europace\/eut422","volume":"16","author":"WL Gali","year":"2014","unstructured":"Gali WL, Sarabanda AV, Baggio JM, Ferreira LG, Gomes GG, Marin-Neto JA, Junqueira LF. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone. Europace. 2014;16(5):674\u201380.","journal-title":"Europace"},{"key":"2324_CR15","doi-asserted-by":"crossref","unstructured":"Morillo CA, Marin-Neto JA, Avezum A, Sosa-Estani S, Rassi A, Jr., Rosas F, Villena E, Quiroz R, Bonilla R, Britto C, et al. Randomized Trial of Benznidazole for Chronic Chagas\u2019 Cardiomyopathy. N Engl J Med 2015;373(14):1295-1306.","DOI":"10.1056\/NEJMoa1507574"},{"issue":"3","key":"2324_CR16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091154","volume":"9","author":"C Poveda","year":"2014","unstructured":"Poveda C, Fresno M, Girones N, Martins-Filho OA, Ramirez JD, Santi-Rocca J, Marin-Neto JA, Morillo CA, Rosas F, Guhl F. Cytokine profiling in Chagas disease: towards understanding the association with infecting Trypanosoma cruzi discrete typing units (a BENEFIT TRIAL sub-study). PLoS One. 2014;9(3):e91154.","journal-title":"PLoS One"},{"key":"2324_CR17","unstructured":"Gil Flores J GJE, Rodr\u00edguez G\u00f3mez G. An\u00e1lisis Discriminante, vol. 12. Madrid, Espa\u00f1a: Editorial La Muralla; 2001."},{"key":"2324_CR18","first-page":"182","volume":"105","author":"EM Jones","year":"1992","unstructured":"Jones EM, Colley DG, Tostes S, Lopes ER, Vnencak-Jones CL, McCurley TL. A Trypanosoma cruzi DNA sequence amplified from inflammatory lesions in human chagasic cardiomyopathy. Trans Assoc Am Phys. 1992;105:182\u20139.","journal-title":"Trans Assoc Am Phys"},{"issue":"2","key":"2324_CR19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/1054-8807(93)90021-S","volume":"2","author":"L Higuchi Mde","year":"1993","unstructured":"Higuchi Mde L, De Brito T, Martins Reis M, Barbosa A, Bellotti G, Pereira-Barreto AC, Pileggi F. Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: Light microscopy and immunohistochemical findings. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology. 1993;2(2):101\u20136.","journal-title":"Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology"},{"issue":"4","key":"2324_CR20","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1128\/AAC.49.4.1521-1528.2005","volume":"49","author":"S Garcia","year":"2005","unstructured":"Garcia S, Ramos CO, Senra JF, Vilas-Boas F, Rodrigues MM, Campos-de-Carvalho AC, Ribeiro-Dos-Santos R, Soares MB. Treatment with benznidazole during the chronic phase of experimental Chagas\u2019 disease decreases cardiac alterations. Antimicrob Agents Chemother. 2005;49(4):1521\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"2324_CR21","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijcard.2015.04.061","volume":"189","author":"AA Carmo","year":"2015","unstructured":"Carmo AA, Rocha MO, Silva JL, Ianni BM, Fernandes F, Sabino EC, Ribeiro AL. Amiodarone and Trypanosoma cruzi parasitemia in patients with Chagas disease. Int J Cardiol. 2015;189:182\u20134.","journal-title":"Int J Cardiol"},{"issue":"6","key":"2324_CR22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0002-9149(86)90765-4","volume":"57","author":"I Mendoza","year":"1986","unstructured":"Mendoza I, Camardo J, Moleiro F, Castellanos A, Medina V, Gomez J, Acquatella H, Casal H, Tortoledo F, Puigbo J. Sustained ventricular tachycardia in chronic chagasic myocarditis: electrophysiologic and pharmacologic characteristics. Am J Cardiol. 1986;57(6):423\u20137.","journal-title":"Am J Cardiol"},{"key":"2324_CR23","doi-asserted-by":"crossref","first-page":"798078","DOI":"10.1155\/2014\/798078","volume":"2014","author":"IR Pereira","year":"2014","unstructured":"Pereira IR, Vilar-Pereira G, Silva AA, Moreira OC, Britto C, Sarmento ED, Lannes-Vieira J. Tumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental Chagas' heart disease. Mediat Inflamm. 2014;2014:798078.","journal-title":"Mediat Inflamm"},{"key":"2324_CR24","first-page":"914326","volume":"2014","author":"LG Nogueira","year":"2014","unstructured":"Nogueira LG, Santos RH, Fiorelli AI, Mairena EC, Benvenuti LA, Bocchi EA, Stolf NA, Kalil J, Cunha-Neto E. Myocardial gene expression of T-bet, GATA-3, Ror-gammat, FoxP3, and hallmark cytokines in chronic Chagas disease cardiomyopathy: an essentially unopposed TH1-type response. Mediat Inflamm. 2014;2014:914326.","journal-title":"Mediat Inflamm"},{"issue":"3","key":"2324_CR25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.autrev.2010.09.019","volume":"10","author":"E Cunha-Neto","year":"2011","unstructured":"Cunha-Neto E, Teixeira PC, Fonseca SG, Bilate AM, Kalil J. Myocardial gene and protein expression profiles after autoimmune injury in Chagas\u2019 disease cardiomyopathy. Autoimmun Rev. 2011;10(3):163\u20135.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"2324_CR26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/clpt.2012.102","volume":"92","author":"TC Araujo-Jorge","year":"2012","unstructured":"Araujo-Jorge TC, Waghabi MC, Bailly S, Feige JJ. The TGF-beta pathway as an emerging target for Chagas disease therapy. Clin Pharmacol Ther. 2012;92(5):613\u201321.","journal-title":"Clin Pharmacol Ther"},{"key":"2324_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-015-0179-x","volume":"16","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Sun Q, Zeng Z, Li Q, Zhou S, Zhou M, Xue Y, Cheng X, Xia Y, Wang Q, et al. Regulation of SCN3B\/scn3b by Interleukin 2 (IL-2): IL-2 modulates SCN3B\/scn3b transcript expression and increases sodium current in myocardial cells. BMC Cardiovasc Disord. 2016;16:1.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"2324_CR28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.imlet.2015.06.009","volume":"167","author":"A Aksyonov","year":"2015","unstructured":"Aksyonov A, Mitrokhin VM, Mladenov MI. Effects of interleukin-2 on bioelectric activity of rat atrial myocardium under normal conditions and during gradual stretching. Immunol Lett. 2015;167(1):23\u20138.","journal-title":"Immunol Lett"},{"issue":"1","key":"2324_CR29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cyto.2015.01.026","volume":"73","author":"F Cabrera-Bueno","year":"2015","unstructured":"Cabrera-Bueno F, Medina-Palomo C, Ruiz-Salas A, Flores A, Rodriguez-Losada N, Barrera A, Jimenez-Navarro M, Alzueta J. Serum levels of interleukin-2 predict the recurrence of atrial fibrillation after pulmonary vein ablation. Cytokine. 2015;73(1):74\u20138.","journal-title":"Cytokine"},{"issue":"8","key":"2324_CR30","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1540-8167.1994.tb01191.x","volume":"5","author":"AC Carvalho de","year":"1994","unstructured":"de Carvalho AC, Masuda MO, Tanowitz HB, Wittner M, Goldenberg RC, Spray DC. Conduction defects and arrhythmias in Chagas' disease: possible role of gap junctions and humoral mechanisms. J Cardiovasc Electrophysiol. 1994;5(8):686\u201398.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"1","key":"2324_CR31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1128\/AAC.01129-10","volume":"55","author":"D Adesse","year":"2011","unstructured":"Adesse D, Azzam EM, Meirelles Mde N, Urbina JA, Garzoni LR. Amiodarone inhibits Trypanosoma cruzi infection and promotes cardiac cell recovery with gap junction and cytoskeleton reassembly in vitro. Antimicrob Agents Chemother. 2011;55(1):203\u201310.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2324_CR32","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4269\/ajtmh.1993.48.637","volume":"48","author":"DD Reis","year":"1993","unstructured":"Reis DD, Jones EM, Tostes Jr S, Lopes ER, Gazzinelli G, Colley DG, McCurley TL. Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. AmJTrop Med Hyg. 1993;48(5):637\u201344.","journal-title":"AmJTrop Med Hyg"},{"issue":"1","key":"2324_CR33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/jaut.2001.0523","volume":"17","author":"LC Abel","year":"2001","unstructured":"Abel LC, Rizzo LV, Ianni B, Albuquerque F, Bacal F, Carrara D, Bocchi EA, Teixeira HC, Mady C, Kalil J, et al. Chronic Chagas\u2019 disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J Autoimmun. 2001;17(1):99\u2013107.","journal-title":"J Autoimmun"},{"issue":"2","key":"2324_CR34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/clin.1997.4335","volume":"83","author":"MM Reis","year":"1997","unstructured":"Reis MM, Higuchi Mde L, Benvenuti LA, Aiello VD, Gutierrez PS, Bellotti G, Pileggi F. An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. Clin Immunol Immunopathol. 1997;83(2):165\u201372.","journal-title":"Clin Immunol Immunopathol"},{"issue":"7","key":"2324_CR35","doi-asserted-by":"crossref","first-page":"11324","DOI":"10.3390\/ijms150711324","volume":"15","author":"CM Steyers 3rd","year":"2014","unstructured":"Steyers 3rd CM, Miller Jr FJ. Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci. 2014;15(7):11324\u201349.","journal-title":"Int J Mol Sci"},{"issue":"15\u201316","key":"2324_CR36","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.molimm.2011.05.008","volume":"48","author":"JL Silva-Filho","year":"2011","unstructured":"Silva-Filho JL, Souza MC, Henriques M, Morrot A, Savino W, Nunes MP, Caruso-Neves C, Pinheiro AA. AT1 receptor-mediated angiotensin II activation and chemotaxis of T lymphocytes. Mol Immunol. 2011;48(15\u201316):1835\u201343.","journal-title":"Mol Immunol"},{"issue":"6","key":"2324_CR37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/jir.2008.0082.2906","volume":"29","author":"L Hak","year":"2009","unstructured":"Hak L, Mysliwska J, Wieckiewicz J, Szyndler K, Siebert J, Rogowski J. Interleukin-2 as a predictor of early postoperative atrial fibrillation after cardiopulmonary bypass graft (CABG). J Interf Cytokine Res. 2009;29(6):327\u201332.","journal-title":"J Interf Cytokine Res"},{"issue":"3","key":"2324_CR38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cyto.2007.08.013","volume":"40","author":"I Rizos","year":"2007","unstructured":"Rizos I, Tsiodras S, Rigopoulos AG, Dragomanovits S, Kalogeropoulos AS, Papathanasiou S, Sakadakis EA, Kremastinos DT. Interleukin-2 serum levels variations in recent onset atrial fibrillation are related with cardioversion outcome. Cytokine. 2007;40(3):157\u201364.","journal-title":"Cytokine"},{"issue":"1","key":"2324_CR39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/1535370214544263","volume":"240","author":"SM Cheng","year":"2015","unstructured":"Cheng SM, Lin WH, Lin CS, Ho LJ, Tsai TN, Wu CH, Lai JH, Yang SP. Modulation of both activator protein-1 and nuclear factor-kappa B signal transduction of human T cells by amiodarone. Exp Biol Med. 2015;240(1):99\u2013108.","journal-title":"Exp Biol Med"},{"issue":"5","key":"2324_CR40","first-page":"538","volume":"59","author":"G Ozbakis-Dengiz","year":"2007","unstructured":"Ozbakis-Dengiz G, Halici Z, Akpinar E, Cadirci E, Bilici D, Gursan N. Role of polymorphonuclear leukocyte infiltration in the mechanism of anti-inflammatory effect of amiodarone. Pharmacological reports: PR. 2007;59(5):538\u201344.","journal-title":"Pharmacological reports: PR"},{"issue":"5\u20136","key":"2324_CR41","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3109\/08830189809043008","volume":"16","author":"F Fossiez","year":"1998","unstructured":"Fossiez F, Banchereau J, Murray R, Van Kooten C, Garrone P, Lebecque S. Interleukin-17. Int Rev Immunol. 1998;16(5\u20136):541\u201351.","journal-title":"Int Rev Immunol"},{"issue":"Suppl 2","key":"2324_CR42","volume":"130","author":"Y Tanigaito","year":"2014","unstructured":"Tanigaito Y, Sato K, Kitamura K, Suzuki A, Futase A, Shiga T, Hagiwara N. Abstract 15132: Amiodarone Treatments Improve the Inflammation in Heart Failure. Circulation. 2014;130(Suppl 2):A15132.","journal-title":"Circulation"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2324-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T21:21:11Z","timestamp":1568928071000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2324-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,21]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2324"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2324-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,21]]},"article-number":"221"}}